348 related articles for article (PubMed ID: 17368668)
21. High-resolution structures of human aldose reductase holoenzyme in complex with stereoisomers of the potent inhibitor Fidarestat: stereospecific interaction between the enzyme and a cyclic imide type inhibitor.
El-Kabbani O; Darmanin C; Oka M; Schulze-Briese C; Tomizaki T; Hazemann I; Mitschler A; Podjarny A
J Med Chem; 2004 Aug; 47(18):4530-7. PubMed ID: 15317464
[TBL] [Abstract][Full Text] [Related]
22. Requirements for specific binding of low affinity inhibitor fragments to the SH2 domain of (pp60)Src are identical to those for high affinity binding of full length inhibitors.
Lange G; Lesuisse D; Deprez P; Schoot B; Loenze P; Bénard D; Marquette JP; Broto P; Sarubbi E; Mandine E
J Med Chem; 2003 Nov; 46(24):5184-95. PubMed ID: 14613321
[TBL] [Abstract][Full Text] [Related]
23. FlexE: efficient molecular docking considering protein structure variations.
Claussen H; Buning C; Rarey M; Lengauer T
J Mol Biol; 2001 Apr; 308(2):377-95. PubMed ID: 11327774
[TBL] [Abstract][Full Text] [Related]
24. The crystal structures of human alpha-thrombin complexed with active site-directed diamino benzo[b]thiophene derivatives: a binding mode for a structurally novel class of inhibitors.
Chirgadze NY; Sall DJ; Briggs SL; Clawson DK; Zhang M; Smith GF; Schevitz RW
Protein Sci; 2000 Jan; 9(1):29-36. PubMed ID: 10739244
[TBL] [Abstract][Full Text] [Related]
25. Docking and molecular dynamics studies toward the binding of new natural phenolic marine inhibitors and aldose reductase.
Wang Z; Ling B; Zhang R; Suo Y; Liu Y; Yu Z; Liu C
J Mol Graph Model; 2009 Sep; 28(2):162-9. PubMed ID: 19616461
[TBL] [Abstract][Full Text] [Related]
26. Thermodynamic characterization of allosteric glycogen phosphorylase inhibitors.
Anderka O; Loenze P; Klabunde T; Dreyer MK; Defossa E; Wendt KU; Schmoll D
Biochemistry; 2008 Apr; 47(16):4683-91. PubMed ID: 18373353
[TBL] [Abstract][Full Text] [Related]
27. Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors.
Ferrari AM; Degliesposti G; Sgobba M; Rastelli G
Bioorg Med Chem; 2007 Dec; 15(24):7865-77. PubMed ID: 17870536
[TBL] [Abstract][Full Text] [Related]
28. Structural features of the aldose reductase and aldehyde reductase inhibitor-binding sites.
El-Kabbani O; Wilson DK; Petrash M; Quiocho FA
Mol Vis; 1998 Sep; 4():19. PubMed ID: 9756955
[TBL] [Abstract][Full Text] [Related]
29. Water makes the difference: rearrangement of water solvation layer triggers non-additivity of functional group contributions in protein-ligand binding.
Biela A; Betz M; Heine A; Klebe G
ChemMedChem; 2012 Aug; 7(8):1423-34. PubMed ID: 22733601
[TBL] [Abstract][Full Text] [Related]
30. Expect the unexpected or caveat for drug designers: multiple structure determinations using aldose reductase crystals treated under varying soaking and co-crystallisation conditions.
Steuber H; Zentgraf M; Gerlach C; Sotriffer CA; Heine A; Klebe G
J Mol Biol; 2006 Oct; 363(1):174-87. PubMed ID: 16952371
[TBL] [Abstract][Full Text] [Related]
31. Crystal structure analysis and in silico pKa calculations suggest strong pKa shifts of ligands as driving force for high-affinity binding to TGT.
Ritschel T; Hoertner S; Heine A; Diederich F; Klebe G
Chembiochem; 2009 Mar; 10(4):716-27. PubMed ID: 19199329
[TBL] [Abstract][Full Text] [Related]
32. Ultrahigh resolution drug design I: details of interactions in human aldose reductase-inhibitor complex at 0.66 A.
Howard EI; Sanishvili R; Cachau RE; Mitschler A; Chevrier B; Barth P; Lamour V; Van Zandt M; Sibley E; Bon C; Moras D; Schneider TR; Joachimiak A; Podjarny A
Proteins; 2004 Jun; 55(4):792-804. PubMed ID: 15146478
[TBL] [Abstract][Full Text] [Related]
33. Structure of aldehyde reductase in ternary complex with a 5-arylidene-2,4-thiazolidinedione aldose reductase inhibitor.
Carbone V; Giglio M; Chung R; Huyton T; Adams J; Maccari R; Ottana R; Hara A; El-Kabbani O
Eur J Med Chem; 2010 Mar; 45(3):1140-5. PubMed ID: 20036445
[TBL] [Abstract][Full Text] [Related]
34. Van der Waals interactions dominate ligand-protein association in a protein binding site occluded from solvent water.
Barratt E; Bingham RJ; Warner DJ; Laughton CA; Phillips SE; Homans SW
J Am Chem Soc; 2005 Aug; 127(33):11827-34. PubMed ID: 16104761
[TBL] [Abstract][Full Text] [Related]
35. Pursuing aldose reductase inhibitors through in situ cross-docking and similarity-based virtual screening.
Cosconati S; Marinelli L; La Motta C; Sartini S; Da Settimo F; Olson AJ; Novellino E
J Med Chem; 2009 Sep; 52(18):5578-81. PubMed ID: 19719141
[TBL] [Abstract][Full Text] [Related]
36. Thermodynamics of binding of heterobidentate ligands consisting of spacer-connected acarbose and beta-cyclodextrin to the catalytic and starch-binding domains of glucoamylase from Aspergillus niger shows that the catalytic and starch-binding sites are in close proximity in space.
Sigurskjold BW; Christensen T; Payre N; Cottaz S; Driguez H; Svensson B
Biochemistry; 1998 Jul; 37(29):10446-52. PubMed ID: 9671514
[TBL] [Abstract][Full Text] [Related]
37. Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors.
Maccari R; Ottanà R; Curinga C; Vigorita MG; Rakowitz D; Steindl T; Langer T
Bioorg Med Chem; 2005 Apr; 13(8):2809-23. PubMed ID: 15781392
[TBL] [Abstract][Full Text] [Related]
38. Thermodynamic cycle analysis and inhibitor design against beta-lactamase.
Roth TA; Minasov G; Morandi S; Prati F; Shoichet BK
Biochemistry; 2003 Dec; 42(49):14483-91. PubMed ID: 14661960
[TBL] [Abstract][Full Text] [Related]
39. A structural and thermodynamic escape mechanism from a drug resistant mutation of the HIV-1 protease.
Vega S; Kang LW; Velazquez-Campoy A; Kiso Y; Amzel LM; Freire E
Proteins; 2004 May; 55(3):594-602. PubMed ID: 15103623
[TBL] [Abstract][Full Text] [Related]
40. Binding thermodynamics of substituted diaminopyrimidine renin inhibitors.
Sarver RW; Peevers J; Cody WL; Ciske FL; Dyer J; Emerson SD; Hagadorn JC; Holsworth DD; Jalaie M; Kaufman M; Mastronardi M; McConnell P; Powell NA; Quin J; Van Huis CA; Zhang E; Mochalkin I
Anal Biochem; 2007 Jan; 360(1):30-40. PubMed ID: 17113558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
